Results 211 to 220 of about 131,241 (336)

Intrinsic PDL1 Signaling Modulates TGFBI‐Mediated Growth Suppression in Lung Adenocarcinoma

Cancer Science, EarlyView.
Programmed death ligand 1 (PDL1) is known for suppressing T‐cell immunity, but its intrinsic role in oncogenesis remains unclear. This study demonstrates that PDL1 expression in lung adenocarcinoma (ADC) inhibits tumor cell growth by reducing FAK activation and regulating the CITED2‐p21CIP1 axis, leading to cell growth arrest.
Thi Thanh Nha Nguyen, Pei‐Yu Chen, Ming‐Yi Zheng, Ting‐Kuang Lin, Chun‐Chao Wang, Yuh‐Min Chen, Yu‐Ting Chou   +6 more
wiley   +1 more source

Cyclin D2 - a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis. [PDF]

Front Oncol
Wang L, Qu W, Yang Z.
europepmc   +1 more source

PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma [PDF]

, 2000
Helga B. Salvesen, Nicola MacDonald, Andy Ryan, Ian Jacobs, Eric D. Lynch, Lars A. Akslen, Soma Das   +6 more
openalex   +1 more source

Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women

Clinical Endocrinology, EarlyView.
ABSTRACT Context Androgen excess is common in women and refers to clinical or biochemical evidence of elevated androgenic steroids such as testosterone. It is associated with underlying polycystic ovary syndrome in the majority of cases. However severe androgen excess is less common and may indicate the presence of underlying adrenal or ovarian ...
Yasir S. Elhassan, James M. Hawley, Leanne Cussen, Ali Abbara, Sophie A. Clarke, Punith Kempegowda, Rima K. Dhillon‐Smith, Puja Thadani, Maureen Busby, Lucy Owusu‐Darkwah, Rachel Marrington, W. Colin Duncan, Robert K. Semple, Richard Quinton, Michael W. O'Reilly   +14 more
wiley   +1 more source

Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications. [PDF]

Biomedicines
Yu H, Zu L, Zang Y, Teng F, Wang T, Wu M, Wang Y, Xue F.   +7 more
europepmc   +1 more source

Assessment of myometrial infiltration and preoperative staging by transvaginal ultrasound in patients with endometrial carcinoma

, 1995
Germain Weber, E. Merz, Franz Bahlmann, M. Mitze, W. Weikel, P. G. Knapstein   +5 more
openalex   +1 more source

CD105 (Endoglin) Expression as a Prognostic Marker in Aggressive Papillary Thyroid Carcinoma

Clinical Endocrinology, EarlyView.
ABSTRACT Background Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy, with a generally favourable prognosis. However, a subset of PTC cases exhibit aggressive behaviour, including lymph node and distant organ metastases. Identifying biomarkers that can differentiate between benign and malignant lesions, as well as predict
İlker Çordan, Tuğba Günler
wiley   +1 more source

Updated Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma: The Polish Society of Gynecological Oncology (2025v). [PDF]

Curr Oncol
Sznurkowski JJ, Bodnar L, Dańska-Bidzińska A, Marszałek A, Blecharz P, Chudecka-Głaz A, Klasa-Mazurkiewicz D, Kowalik A, Zołciak-Siwinska A, Zielinska A, Bidziński M, Sawicki W.   +11 more
europepmc   +1 more source

PMS2 c.2117del (p.Lys706Serfs*19) is the Most Frequent Cancer‐Associated Founder Pathogenic Variant in the French‐Canadian Population of Quebec, Canada

Clinical Genetics, EarlyView.
Using haplotype analysis, we characterized PMS2 c.2117del, identified in 22 families, as a founder variant in the French‐Canadian population of Quebec. It is the most frequent cancer‐associated founder variant in French‐Canadians, with over‐representation in five regions of Quebec. The variant contributed to colorectal and endometrial cancer incidence.
Anne‐Laure Chong, Alejandro Mejia‐Garcia, Supriya Behl, Zaki El Haffaf, Sébastien Chénier, Bruno Maranda, Valérie Désilets, Sébastien Lévesque, Lysanne Castonguay, Anne‐Marie Mes‐Masson, Sylvie Giroux, François Rousseau, Nancy Hamel, George Chong, Simon Gravel, William D. Foulkes   +15 more
wiley   +1 more source

Sentinel lymph node biopsy in low- and intermediaterisk endometrial carcinoma. [PDF]

Obstet Gynecol Sci
Iavazzo C, Gkegkes ID.
europepmc   +1 more source